Physician profile
Karim Nathan
NPI 1639570849
$41,884.58
in general payments reported to CMS, 2019-2025
21 companies · $1,121 in 2025
The $1,121 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $21K · 2021: $1,607 · 2022: $1,136 · 2023: $909 · 2024: $417 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,447.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $26,411.16 | 2019-2020 | |
| Boston Scientific Corporation | $10,530.59 | 2019-2025 | Ingevity+, Watchman Flx, Watchman Access System |
| Abbott Laboratories | $1,656.30 | 2019-2025 | Navitor, Mitraclip, Jot Dx |
| Medtronic, INC. | $1,187.91 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Sphere-9 |
| Biosense Webster, INC. | $450.29 | 2021-2025 | Octaray Mapping Catheter, Carto 3 |
| Sanofi-Aventis U.S. LLC | $327.29 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $256.49 | 2021-2025 | Lifevest |
| Pfizer INC. | $201.79 | 2019-2025 | |
| Amgen INC. | $172.73 | 2019-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $136.21 | 2022-2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $126.21 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $123.50 | 2019 | |
| Merck Sharp & Dohme LLC | $69.63 | 2022-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.36 | 2019-2023 | Jardiance |
| Philips North America LLC | $37.83 | 2022-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $36.77 | 2021-2025 | Sotalol Hydrochloride |
| Novartis Pharmaceuticals Corporation | $35.41 | 2023 | |
| Baxter Healthcare | $23.45 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Cvrx, INC. | $19.06 | 2025 | Barostim Neo System |
| Vital Connect, INC | $17.76 | 2025 | Vitalpatch Rtm |
| Scpharmaceuticals INC. | $15.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karim Nathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.